Abstract

There is accumulating evidence that endogenous steroids and non-polar drugs are involved in the regulation of mitochondrial physiology. Many of these hydrophobic compounds interact with the Voltage Dependent Anion Channel (VDAC). This major metabolite channel in the mitochondrial outer membrane (MOM) regulates the exchange of ions and water-soluble metabolites, such as ATP and ADP, across the MOM, thus governing mitochondrial respiration. Proteomics and biochemical approaches together with molecular dynamics simulations have identified an impressively large number of non-polar compounds, including endogenous, able to bind to VDAC. These findings have sparked speculation that both natural steroids and synthetic hydrophobic drugs regulate mitochondrial physiology by directly affecting VDAC ion channel properties and modulating its metabolite permeability. Here we evaluate recent studies investigating the effect of identified VDAC-binding natural steroids and non-polar drugs on VDAC channel functioning. We argue that while many compounds are found to bind to the VDAC protein, they do not necessarily affect its channel functions in vitro. However, they may modify other aspects of VDAC physiology such as interaction with its cytosolic partner proteins or complex formation with other mitochondrial membrane proteins, thus altering mitochondrial function.

Highlights

  • The role of mitochondria in oxidative metabolism, apoptosis, and steroidogenesis is well established and mitochondrial malfunction plays a central role in a broad range of disorders

  • Tight regulation of mitochondrial outer membrane (MOM) permeability is crucial for cell metabolism, and its alteration is often associated with mitochondrial dysfunction

  • voltage-dependent anion channel (VDAC) constitutes the main pathway for the exchange of small ions, ATP, ADP, and other water-soluble mitochondrial metabolites across the MOM and serves as a conjunction point for a variety of cell signals through its association with numerous cytosolic proteins (Colombini, 2004; Lemasters and Holmuhamedov, 2006; Rostovtseva and Bezrukov, 2008), serving as a global regulator of mitochondrial energetics and cell metabolism

Read more

Summary

INTRODUCTION

The role of mitochondria in oxidative metabolism, apoptosis, and steroidogenesis is well established and mitochondrial malfunction plays a central role in a broad range of disorders. Due to its central role in controlling MOM permeability, and mitochondrial function, VDAC is emerging as a promising pharmacological target for treating a wide variety of mitochondria-associated pathologies (Shoshan-Barmatz and Ben-Hail, 2012; Camara et al, 2017; Karachitos et al, 2017; Shoshan-Barmatz et al, 2018b) In this context, proteomics and biochemical approaches along with molecular dynamics simulations have identified a large number of non-polar compounds, such as natural and synthetic steroids, smallmolecule anticancer and neuroprotective drugs, and general anesthetics, which are able to bind to VDAC (Shoshan-Barmatz and Ben-Hail, 2012; Magri and Messina, 2017; Reina and De Pinto, 2017; Leanza et al, 2019).

Method of VDAC binding determination
Findings
CONCLUSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call